FI890050A - Nya 3,5-dihydroxikarbonsyror och deras derivat, foerfarande foer deras framstaellning, deras anvaendning som laekemedel, farmaceutiska preparat och mellanprodukter. - Google Patents
Nya 3,5-dihydroxikarbonsyror och deras derivat, foerfarande foer deras framstaellning, deras anvaendning som laekemedel, farmaceutiska preparat och mellanprodukter. Download PDFInfo
- Publication number
- FI890050A FI890050A FI890050A FI890050A FI890050A FI 890050 A FI890050 A FI 890050A FI 890050 A FI890050 A FI 890050A FI 890050 A FI890050 A FI 890050A FI 890050 A FI890050 A FI 890050A
- Authority
- FI
- Finland
- Prior art keywords
- deras
- och
- dihydroxikarbonsyror
- nya
- derivat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
- C07C45/305—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/16—Saturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/213—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C49/217—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the aromatic rings
- C07C49/223—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the aromatic rings polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
- C07C49/567—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/782—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
- C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3800439 | 1988-01-09 | ||
DE3800785A DE3800785A1 (de) | 1988-01-09 | 1988-01-14 | Substituierte 7-(pyridazin-5-yl)-3,5-dihydroxyheptan(en)- saeuren, ihre entsprechenden (delta)-lactone bzw. derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
Publications (2)
Publication Number | Publication Date |
---|---|
FI890050A0 FI890050A0 (fi) | 1989-01-05 |
FI890050A true FI890050A (fi) | 1989-07-10 |
Family
ID=25863830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI890050A FI890050A (fi) | 1988-01-09 | 1989-01-05 | Nya 3,5-dihydroxikarbonsyror och deras derivat, foerfarande foer deras framstaellning, deras anvaendning som laekemedel, farmaceutiska preparat och mellanprodukter. |
Country Status (15)
Country | Link |
---|---|
US (1) | US4946841A (fi) |
EP (1) | EP0324347A3 (fi) |
JP (1) | JPH01213270A (fi) |
KR (1) | KR890011859A (fi) |
AU (1) | AU612449B2 (fi) |
DE (1) | DE3800785A1 (fi) |
DK (1) | DK5289A (fi) |
FI (1) | FI890050A (fi) |
HU (1) | HU202502B (fi) |
IL (1) | IL88908A0 (fi) |
NO (1) | NO890062L (fi) |
NZ (1) | NZ227551A (fi) |
PH (1) | PH26148A (fi) |
PT (1) | PT89409B (fi) |
ZA (1) | ZA89121B (fi) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3826814A1 (de) * | 1988-08-06 | 1990-02-08 | Hoechst Ag | Neue 6-fluor-3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
DE3832570A1 (de) * | 1988-09-24 | 1990-03-29 | Hoechst Ag | 7-substituierte derivate der 3,5-dihydroxyhept-6-insaeure, verfahren zur ihrer herstellung, ihre verwendung als arzneimittel, sowie zwischenprodukte |
JPH02188571A (ja) * | 1988-10-03 | 1990-07-24 | Glaxo Group Ltd | 化合物 |
AU637408B2 (en) * | 1989-10-10 | 1993-05-27 | Glaxo Group Limited | Substituted N-vinyl imidazole derivatives. |
IT1237792B (it) * | 1989-12-21 | 1993-06-17 | Zambon Spa | Composti attivi come inibitori dell'enzima hmg-coa reduttasi |
JPH054943A (ja) * | 1990-08-30 | 1993-01-14 | Sagami Chem Res Center | 光学活性β,δ−ジケト酸エステル及びその還元体 |
DE4208051A1 (de) * | 1992-03-13 | 1993-09-16 | Bayer Ag | Substituierte phenylessigsaeureamide |
DE4208052A1 (de) * | 1992-03-13 | 1993-09-16 | Bayer Ag | Imidazolyl substituierte phenylessigsaeureamide |
DE4212796A1 (de) * | 1992-04-16 | 1993-10-21 | Bayer Ag | Propenoyl-imidazolderivate |
DE4215588A1 (de) * | 1992-05-12 | 1993-11-18 | Bayer Ag | Biphenylmethyl-substituierte Pyridone |
DE4215587A1 (de) * | 1992-05-12 | 1993-11-18 | Bayer Ag | Sulfonylbenzyl-substituierte Benzo- und Pyridopyridone |
DE4220983A1 (de) * | 1992-06-26 | 1994-01-05 | Bayer Ag | Imidazolyl-substituierte Phenylpropion- und -zimtsäurederivate |
DE4319041A1 (de) * | 1992-10-23 | 1994-04-28 | Bayer Ag | Trisubstituierte Biphenyle |
EP1628665A2 (en) * | 2003-04-16 | 2006-03-01 | Amgen Inc. | 3-phenyl-4-(pyrimidin-2-yl)-6-(piperidin-4-yl) derivatives and related compounds as tnf-alpha and il-1 inhibitors for the treatment of inflammations |
US8372877B2 (en) | 2010-04-16 | 2013-02-12 | Cumberland Pharmaceuticals | Stabilized statin formulations |
CN103153299A (zh) | 2010-10-06 | 2013-06-12 | 国立大学法人东京大学 | 淋巴水肿预防治疗剂 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2752820A1 (de) * | 1977-11-26 | 1979-05-31 | Bayer Ag | Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
US4375475A (en) * | 1979-08-17 | 1983-03-01 | Merck & Co., Inc. | Substituted pyranone inhibitors of cholesterol synthesis |
US4540796A (en) * | 1982-05-03 | 1985-09-10 | Merck & Co., Inc. | Process for preparing inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase via a chiral synthon |
WO1986000307A2 (en) * | 1984-06-22 | 1986-01-16 | Sandoz Ag | Pyrazole analogs of mevalonolactone and derivatives thereof, processes for their production and their use |
US4613610A (en) * | 1984-06-22 | 1986-09-23 | Sandoz Pharmaceuticals Corp. | Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives |
US4647576A (en) * | 1984-09-24 | 1987-03-03 | Warner-Lambert Company | Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis |
US4681893A (en) * | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
US4735958A (en) * | 1986-12-22 | 1988-04-05 | Warner-Lambert Company | Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-substituted-1H-pyrrol-1-yl]-ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one inhibitors of cholesterol biosynthesis |
US4761419A (en) * | 1987-12-07 | 1988-08-02 | Warner-Lambert Company | 6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
DE3826814A1 (de) * | 1988-08-06 | 1990-02-08 | Hoechst Ag | Neue 6-fluor-3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
-
1988
- 1988-01-14 DE DE3800785A patent/DE3800785A1/de not_active Withdrawn
-
1989
- 1989-01-03 EP EP19890100031 patent/EP0324347A3/de not_active Withdrawn
- 1989-01-05 FI FI890050A patent/FI890050A/fi not_active IP Right Cessation
- 1989-01-06 NZ NZ227551A patent/NZ227551A/en unknown
- 1989-01-06 PH PH38012A patent/PH26148A/en unknown
- 1989-01-06 PT PT89409A patent/PT89409B/pt not_active IP Right Cessation
- 1989-01-06 NO NO89890062A patent/NO890062L/no unknown
- 1989-01-06 ZA ZA89121A patent/ZA89121B/xx unknown
- 1989-01-06 AU AU27780/89A patent/AU612449B2/en not_active Ceased
- 1989-01-06 JP JP64000586A patent/JPH01213270A/ja active Pending
- 1989-01-06 DK DK005289A patent/DK5289A/da not_active Application Discontinuation
- 1989-01-06 US US07/294,096 patent/US4946841A/en not_active Expired - Fee Related
- 1989-01-06 HU HU8945A patent/HU202502B/hu unknown
- 1989-01-07 KR KR1019890000100A patent/KR890011859A/ko unknown
- 1989-01-09 IL IL88908A patent/IL88908A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL88908A0 (en) | 1989-08-15 |
DK5289A (da) | 1989-07-10 |
PT89409B (pt) | 1993-12-31 |
AU612449B2 (en) | 1991-07-11 |
EP0324347A3 (de) | 1990-12-05 |
NO890062L (no) | 1989-07-10 |
DE3800785A1 (de) | 1989-07-20 |
HUT50790A (en) | 1990-03-28 |
FI890050A0 (fi) | 1989-01-05 |
KR890011859A (ko) | 1989-08-23 |
US4946841A (en) | 1990-08-07 |
ZA89121B (en) | 1989-09-27 |
PT89409A (pt) | 1990-02-08 |
DK5289D0 (da) | 1989-01-06 |
NZ227551A (en) | 1990-11-27 |
EP0324347A2 (de) | 1989-07-19 |
NO890062D0 (no) | 1989-01-06 |
HU202502B (en) | 1991-03-28 |
JPH01213270A (ja) | 1989-08-28 |
PH26148A (en) | 1992-03-18 |
AU2778089A (en) | 1989-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI900313A0 (fi) | Nya benzopyranderivat, deras framstaellning och dessa innehaollande farmaceutiska preparat. | |
FI901956A0 (fi) | Nya naftalenylalkyl-3h-1,2,3,5 -oxatiadiazol-2-oxider anvaendbara som antihyperglykemiska medel. | |
FI891227A (fi) | Katekolderivat och farmaceutiska preparat som innehaoller dessa. | |
FI890050A (fi) | Nya 3,5-dihydroxikarbonsyror och deras derivat, foerfarande foer deras framstaellning, deras anvaendning som laekemedel, farmaceutiska preparat och mellanprodukter. | |
FI914319A (fi) | Nya karbocykliska adenosinanaloger anvaendbara som immunosupressanter. | |
FI891449A (fi) | Nya 2,3,4-substituerade imidazoler och 3,4,5-substituerade 1,2,4-triazoler, deras framstaellning och anvaendning. | |
FI903739A0 (fi) | Nya 5-substituerade-1,3,4-tiadiazoler, foerfarande foer deras framstaellning och deras anvaendning som bekaempningsmedel mot skadeinsekter. | |
FI894629A0 (fi) | Nya 3,4-diaminokinolin- och -pyridinfoereningar. | |
FI911606A0 (fi) | Foerfarande foer framstaellning av nya foereningar, som inhiberar trombocytaggregation. | |
FI874020A0 (fi) | Tetrahydrokinolinderivat, foerfarande foer deras framstaellning, deras anvaendning och dessa innehaollande farmaceutiska preparat. | |
FI872897A (fi) | Nya 4-pyridonderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat. | |
FI894798A0 (fi) | Nya 1,4-bensoxazin- och 1,4-bensotiazinderivat och foerfarande foer deras framstaellning. | |
FI883251A0 (fi) | Substituerade bensimidazoler, foerfarande foer deras framstaellnig, dessa innehaollande farmaceutiska preparat och deras anvaendning. | |
FI915435A0 (fi) | Nya leukotrien-b4-derivater, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
FI922773A (fi) | Nya p-substituerade fenyl-4- oksibutanaminderivat, foerfarande foer deras framstaelllning samt farmaceutiska kompositioner innehaollande desamma. | |
FI904191A0 (fi) | Nya aminopropanolderivater, foerfarande foer tillverkning av dessa samt farmaceutiska sammansaettningar som innehaoller dessa. | |
FI892897A (fi) | Nya kondenserade diazepinoner, foerfarande foer deras framstaellning och laekemedel som innehaoller dessa foereningar. | |
FI903237A0 (fi) | Fenoxipyridinaminer och deras derivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
FI900661A0 (fi) | Nya formbara sammansaettningar som haerdas i vaerme. | |
FI894758A (fi) | Derivat av 3-aryloximetyl -cefalosporin, deras framstaellning och medicinska anvaendning. | |
FI892896A (fi) | Nya kondenserade diazepinoner, foerfarande foer deras framstaellning och laekemedel som innehaoller dessa foereningar. | |
FI880357A (fi) | Nya isoxazolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat. | |
FI932034A0 (fi) | Nya 1-azacykloalkanderivat, farmaceutiska sammansaettningar som innehaoller dessa samt foerfarande foer framstaellning daerav | |
FI895899A0 (fi) | Nya trombolytiska proteiner, foerfarande foer deras framstaellning och dessa som aktivaemne innehaollande laekemedel. | |
FI894347A (fi) | 2,3,4,5-tetrahydro-1-benzoxepiner, foerfarande foer deras framstaellning, deras anvaendning och dessa foereningar innehaollande farmaceutiska preparat. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed | ||
MM | Patent lapsed |
Owner name: HOECHST AKTIENGESELLSCHAFT |